Elizabeth A. Garofalo

Filings by Elizabeth A. Garofalo span 3 companies, the busiest being Acadia Pharmaceuticals Inc, Alector, Inc. and Xenon Pharmaceuticals Inc. We count 15 filings; the first trade dates from 29 September 2021 and the latest from 17 June 2026.

Every open-market trade on record is a sale: 2 sales worth €120k. Outside the open market, there are 5 share grants and 6 option exercises.

On 17 June 2026 came the latest disclosure, a share grant in Alector, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.